Thank you for your inquiry regarding the three eligible clinician eCQMs. Please note that eCQMs often have scoring guidance in each respective measure's Guidance or Rate Aggregation sections of the header. In the absence of measure-specific guidance, then you should refer to the report period-specific scoring guidance found in the “Electronic Clinical Quality Measure Logic and Implementation Guidance document and eCQM Flows found in the published eCQM resources in the eCQI Resource Center ( https://ecqi.healthit.gov/ep-ec?qt-tabs_ep=ecqm-resources&global_measure_group=eCQMs ). You can also find scoring examples for the 2024 MIPS performance period. For CMS347v7 (Statin Therapy for the Prevention and Treatment of Cardiovascular Disease), the measure header (under “rate aggregation”) indicates that a single performance rate must be calculated using the following guidance: “For the purposes of this measure, a single performance rate can be calculated as follows: Performance Rate = (Numerator 1 + Numerator 2 + Numerator 3 + Numerator 4)/ [(Denominator 1 - Denominator Exclusions 1- Denominator Exceptions 1) + (Denominator 2 - Denominator Exclusions 2 - Denominator Exceptions 2) + (Denominator 3 - Denominator Exclusions 3 - Denominator Exceptions 3) + (Denominator 4 - Denominator Exclusions 4 - Denominator Exceptions 4)]” For CMS138v12 (Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention), the measure Guidance section notes that "For accountability reporting in the CMS MIPS program, the rate for population 2 is used for performance." CMS156v12 (Use of High-risk Medications in Older Adults) has no unique reporting guidance listed in the measure header. However, note that this multiple-rate measure uses the 1st performance rate for benchmarking in the 2024 MIPP performance period. For any inquiries about CMS quality program reporting requirements or measure scoring, please review the QPP website or contact the QPP Helpdesk at QPP@cms.hhs.gov .